These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 599192)

  • 21. The clinical utility of antihistone antibodies. Autoantibodies reactive with chromatin in systemic lupus erythematosus and drug-induced lupus.
    Burlingame RW
    Clin Lab Med; 1997 Sep; 17(3):367-78. PubMed ID: 9316764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adalimumab-induced lupus erythematosus.
    Martín JM; Ricart JM; Alcácer J; Rausell N; Arana G
    Lupus; 2008 Jul; 17(7):676-8. PubMed ID: 18625641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An acquired inhibitor to factor XIII A case report.
    Shires L; Gomperts ED; Bradlow BA
    S Afr Med J; 1979 Jul; 56(2):70-2. PubMed ID: 483113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peyronie's disease and systemic lupus erythematosus syndrome associated with metoprolol administration: a case report.
    Paladini G
    Int J Tissue React; 1981 Jun; 3(2):95-8. PubMed ID: 7327618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation and mechanism of action of a potent inhibitor of factor XIII function.
    Reed GL; Lukacova D
    Thromb Haemost; 1995 Aug; 74(2):680-5. PubMed ID: 8585006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological abnormalities in patients who had the oculomucocutaneous syndrome associated with practolol therapy.
    Behan PO; Behan WM; Zacharias FJ; Nicholls JT
    Lancet; 1976 Nov; 2(7993):984-7. PubMed ID: 62263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical aspects of drugs and disease of the skin.
    Sneddon IB
    J Clin Pathol Suppl (R Coll Pathol); 1975; 9():54-7. PubMed ID: 134046
    [No Abstract]   [Full Text] [Related]  

  • 28. Haemorrhagic syndrome of autoimmune origin with a specific inhibitor against fibrin stabilizing factor (factor XIII).
    Lorand L; Maldonado N; Fradera J; Atencio AC; Robertson B; Urayama T
    Br J Haematol; 1972 Jul; 23(1):17-27. PubMed ID: 5045959
    [No Abstract]   [Full Text] [Related]  

  • 29. An acquired inhibitor of factor XIII with a qualitative abnormality of fibrin cross-linking.
    Fear JD; Miloszewski KJ; Losowsky MS
    Acta Haematol; 1984; 71(5):304-9. PubMed ID: 6429995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ethosuximide-induced lupus-scleroderma syndrome with disease-specific autoantibodies.
    Toyama T; Asano Y; Taniguchi T; Takahashi T; Ichimura Y; Tamaki Z; Kagami S; Mitsui H; Sato S
    Eur J Dermatol; 2017 Apr; 27(2):196-197. PubMed ID: 28026802
    [No Abstract]   [Full Text] [Related]  

  • 31. Rituximab in the treatment of factor XIII inhibitor possibly caused by Ciprofloxacin.
    Miesbach W
    Thromb Haemost; 2005 May; 93(5):1001-3. PubMed ID: 15886824
    [No Abstract]   [Full Text] [Related]  

  • 32. Practolol-induced autoantibodies and their relation to oculo-cutaneous complications.
    Jachuck SJ; Stephenson J; Bird T; Jackson FS; Clark F
    Postgrad Med J; 1977 Feb; 53(616):75-7. PubMed ID: 141660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reticuloendothelial system Fc receptor function in the drug induced lupus erythematosus syndrome.
    Fields TR; Zarrabi MH; Gerardi EN; Bennett RS; Zucker S; Hamburger MI
    J Rheumatol; 1986 Aug; 13(4):726-31. PubMed ID: 3772920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two cases of late-onset drug-induced lupus erythematosus caused by ticlopidine in elderly men.
    Yokoyama T; Usui T; Kiyama K; Nakashima R; Yukawa N; Kawabata D; Nojima T; Ohmura K; Fujii T; Mimori T
    Mod Rheumatol; 2010 Aug; 20(4):405-9. PubMed ID: 20376687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aggressive fatal case of autoimmune hemorrhaphilia resulting from anti-Factor XIII antibodies.
    Sugiyama H; Uesugi H; Suzuki S; Tanaka K; Souri M; Ichinose A
    Blood Coagul Fibrinolysis; 2013 Jan; 24(1):85-9. PubMed ID: 23183237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neonatal Systemic Lupus Erythematosus Syndrome: a Comprehensive Review.
    Vanoni F; Lava SAG; Fossali EF; Cavalli R; Simonetti GD; Bianchetti MG; Bozzini MA; Agostoni C; Milani GP
    Clin Rev Allergy Immunol; 2017 Dec; 53(3):469-476. PubMed ID: 29116459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-induced lupus: Including anti-tumour necrosis factor and interferon induced.
    Araújo-Fernández S; Ahijón-Lana M; Isenberg DA
    Lupus; 2014 May; 23(6):545-53. PubMed ID: 24557776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary hypertension in systemic lupus erythematosus: a report of three cases.
    Asherson RA; Hackett D; Gharavi AE; Harris EN; Kennedy HG; Hughes GR
    J Rheumatol; 1986 Apr; 13(2):416-20. PubMed ID: 3088276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case with SLE showing acquired low plasma F.XIII level followed by severe hematoma characteristic of F.XIII deficiency].
    Okubo S; Yamano M; Yasunaga K
    Rinsho Ketsueki; 1988 Sep; 29(9):1522-6. PubMed ID: 3216525
    [No Abstract]   [Full Text] [Related]  

  • 40. [The antiphospholipid syndrome in patients with systemic lupus erythematosus and in their closest blood relatives (a preliminary report)].
    Sapsova E; Tsvetkova T; Ledzhev I; Terzieva D
    Vutr Boles; 1990; 29(5):96-9. PubMed ID: 2127871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.